Author:
Halawa Mohamed,Akantibila Maxwell,Reid Briana E.,Carabetta Valerie J.
Abstract
Humans are continually challenged to find new strategies to fight bacterial diseases due to the global health threat of antibiotic resistance. Conventional antibiotics, once hailed as miracle treatments, are progressively losing their effectiveness as drug-resistant bacteria continue to emerge, including multidrug-resistant (MDR) strains. An attractive approach to solving the antibiotic resistance problem is the investigation of other methods, such as therapeutic proteins. Here, we begin with a discussion of antimicrobial resistance and common strategies that bacteria employ to become resistant. Next, we discuss the potential use of antimicrobial peptides and monoclonal antibodies, two types of therapeutic proteins, as possible antimicrobial therapeutics. We discuss their structure, mechanism of action, and highlight examples of possible candidate molecules for clinical use. Finally, we discuss the remaining challenges and explore potential solutions for the implementation of therapeutic proteins into practical clinical use.
Reference166 articles.
1. A review on molecular mechanisms of bacterial resistance to antibiotics;Abebe;Eur. J. Appl. Sci.,2016
2. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection;Acharya;J. Virol.,2014
3. Recent approaches for downplaying antibiotic resistance: Molecular mechanisms;Ahmed;BioMed. Res. Int.,2023
4. Recent insights into structure–function relationships of antimicrobial peptides;Ahmed;J. Food Biochem.,2019
5. The growing genetic and functional diversity of extended spectrum beta-lactamases;Ali;BioMed. Res. Int.,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献